뉴젠아이브 그룹(NIVF) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

Q: What kind of company is 뉴젠아이브 그룹(NIVF)?

뉴젠아이브 그룹(NIVF) belongs to the Healthcare sector and operates in the Medical Care Facilities industry.

Q: What is the market cap of NIVF?

The market cap of NIVF is approximately $4M, ranking 5,736 within its sector.

Q: What is the 52-week high and low for NIVF?

NIVF has recorded a 52-week high of $568.53 and a low of $1.10.

NIVF

NewGenIvf Group Ltd

7월 28일 3:08 PM ET (한국 7/29 04:08)

$1.05

-0.05 ▼ -4.55%

뉴젠아이브 그룹(NIVF) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$4M

스몰캡

P/E

배당수익률

없음

52주 위치

저점 -5% · 고점 -100%

애널리스트

B-

Fundamental health

vs. Medical Care Facilities

수익성

Top 12%

성장

Top 42%

밸류에이션

Top 84%

재무 안정

Top 33%

Index ⓘ	-	P/E ⓘ	-	EPS (ttm) ⓘ	-	Insider Own ⓘ	-	Shs Outstand ⓘ	3.4M	Perf Week ⓘ	-19.85%
Market Cap ⓘ	0.00B	Forward P/E ⓘ	0.04	EPS next Y ⓘ	97.05%	Insider Trans ⓘ	-	Shs Float ⓘ	3.4M	Perf Month ⓘ	-41.56%
Enterprise Value ⓘ	0.01B	PEG ⓘ	0	EPS next Q ⓘ	6.06	Inst Own ⓘ	0.02%	Short Float ⓘ	1.97%	Perf Quarter ⓘ	-82.14%
Income ⓘ	0.01B	P/S ⓘ	0.76	EPS this Y ⓘ	55.92%	Inst Trans ⓘ	-	Short Ratio ⓘ	0.03	Perf Half Y ⓘ	-94.22%
Sales ⓘ	0.00B	P/B ⓘ	0	EPS next 5Y ⓘ	69.1%	ROA ⓘ	-	Short Interest ⓘ	0.07M	Perf YTD ⓘ	-95.77%
Book/sh ⓘ	332.03	P/C ⓘ	4.72	EPS past 3/5Y ⓘ	-90.78% -	ROE ⓘ	-	52W High ⓘ	-99.82% ($568.53)	Perf Year ⓘ	-99.78%
Cash/sh ⓘ	0.22	P/FCF ⓘ	-	Sales past 3/5Y ⓘ	-	ROIC ⓘ	31.87%	52W Low ⓘ	-4.55% ($1.10)	Perf 3Y ⓘ	-100%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	-	EPS Y/Y TTM ⓘ	101.57%	Gross Margin ⓘ	24.2%	Volatility(W/M) ⓘ	8.66% 10.87%	Perf 5Y ⓘ	-
Dividend TTM ⓘ	-	EV/Sales ⓘ	1.49	Sales Y/Y TTM ⓘ	-	Oper. Margin ⓘ	-226.95%	ATR (14) ⓘ	0.21	Perf 10Y ⓘ	-
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	2.9	EPS Q/Q ⓘ	-130.12%	Profit Margin ⓘ	209.02%	RSI (14) ⓘ	28.45	Recom ⓘ	-
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	3.07	Sales Q/Q ⓘ	-	SMA20 ⓘ	-22.6% ($1.36)	Beta ⓘ	-0.01	Target Price ⓘ	$42.36
Payout ⓘ	-	Debt/Eq ⓘ	0.18	Earnings ⓘ	2026/02/25	SMA50 ⓘ	-45.03% ($1.91)	Rel Volume ⓘ	0.16	Prev Close ⓘ	$1.1
Employees ⓘ	87	LT Debt/Eq ⓘ	0.16	EPS/Sales Surpr. ⓘ	-	SMA200 ⓘ	-97.36% ($39.77)	Avg Volume(3M) ⓘ	2.05M	Price ⓘ	$1.05
IPO ⓘ	2022/3/18	Option/Short ⓘ	No/Yes			Trades ⓘ	1096	Volume ⓘ	326,926	Change ⓘ	-4.55%

Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.

📊 NewGenIvf Group Ltd (NIVF) Investment Analysis

What kind of company is NewGenIvf Group Ltd?

뉴젠아이브 그룹(NIVF) 초고성장주

Healthcare · Medical Care Facilities

Small-Cap — Low Volume, High Volatility

A healthcare company specializing in fertility treatment and assisted reproductive technology (ART) services. The company originated from operating fertility clinics in Asia and is now pursuing a business transformation toward a technology licensing platform. It has been strengthening its reproductive technology portfolio through acquisitions such as MicroSort.

Learn more about NewGenIvf Group Ltd →

Market Cap

$0.0B

Approx. KRW 0.0 trillion

⚖️ 0% of Samsung Electronics

Market Cap Rank5736

Employees87people

IPO2022/03/18

Current Price$1.05 ≈ 1,439원

NASD · Thailand

Key Events

⏰ Upcoming events

🔔 Earnings release

The next release date has not been announced yet.

🎯 Ex-dividend date

No scheduled dividends

📜 Recent events

🔔 Earnings release 2026년 2월 25일 (수) · 장 마감 후

Is it profitable?

Financially sound but profitability is low

Losses or thin margins — early-stage growth or weakening competitiveness

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

-226.9%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Net Margin

Share of revenue left after taxes and interest are paid

209.0%

✓ 우수

My positionTop 5%

Low range Average High range

Medical Care Facilities Median 2.5% · Top tier

💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

24.2%

✓ 양호

My positionMid-range

Low range Average High range

Medical Care Facilities Median 19.2% · Top 37%

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROIC

Return generated per dollar invested in the business

31.9%

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 초소형주 Median -77.3% · Top tier

💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

0.18

✓ Very low debt

My positionTop 25%

Low range Average High range

Medical Care Facilities Median 0.92

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

3.07

✓ 우수

My positionTop 25%

Low range Average High range

Medical Care Facilities Median 1.35

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

2.90

✓ 우수

My positionTop 25%

Low range Average High range

Medical Care Facilities Median 1.19

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Positive Outlook

Price targets, growth, and valuation are favorable

애널리스트 목표가

$42.36

현재가 대비 +3934.3%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

예상 PER (Forward)

0.04배

💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인

PEG (성장 반영 밸류)

0.00

저평가

💡 PEG < 1 — 성장 대비 저렴

내년 EPS 예상 성장률

+97.0%

💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상

5년 EPS 예상 연평균

+69.1%

💡 장기 성장 전망. 15% 이상이면 고성장 기업

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Turnaround Expected

Past performance was weak, but the outlook is positive

🔮 How much will it grow? (analyst forecasts)

This Year's EPS Outlook

Projected EPS growth rate for this year

+55.9%

양호

My positionMid-range

Low range Average High range

초고성장주 초소형주 Median 50.1% · Top 44%

Next Year's EPS Outlook

Projected EPS growth rate for next year (analyst consensus)

+97.0%

우수

My positionTop 25%

Low range Average High range

초고성장주 초소형주 Median 35.0% · Top 15%

5-Year EPS CAGR Outlook

Projected average annual EPS growth over the next 5 years

+69.1%

우수

My positionTop 25%

Low range Average High range

초고성장주 초소형주 Median 44.8% · Top 9%

📊 How much has it grown? (actual results)

Past 3-Year EPS

Actual average annual EPS growth over the past 3 years

-90.8%

매우 부진

My positionBottom 5%

Low range Average High range

초고성장주 초소형주 Median 27.5% · Bottom tier

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Underperformed the market by 116%p over the past year

NIVF -99.8% · S&P 500 +16.0%

Excess return vs. market (price-based, ex-dividends)

1-year basis

vs S&P 500

-115.8%p

Significantly behind the market

vs Health Care (XLV)

-119.5%p

Significantly behind the sector average

Rank among peers

1-year return Lowest among peers Based on 10 peers

Current position within 52-week range

Low (-4.5%p) High (-99.8%p)

Current price is 4.5% above the 52-week low and 99.8% below the 52-week high

Recent risk (last 120 trading days)

Max drawdown

-81.5%

Annualized volatility

307.1%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴

Current diagnosis · 2026-07-27

Downtrend zone

Current price $1.05 below the midline ($1.15). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡

Current diagnosis · 2026-07-27

Neutral zone — weak trend

MACD 0.080 · Signal 0.107 · Hist -0.027. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴

Current diagnosis · 2026-07-27

Bearish zone

RSI 47.0 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 9.1.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry

Cheap on Vs. Earnings·Vs. Sales, Pricey on Vs. Assets

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

💵 Vs. Earnings Cheap

🏢 Vs. Assets Pricey

🧾 Vs. Sales Cheap

💵 Vs. Earnings

Forward PER Forward Price-to-Earnings Ratio

PER using next year's estimated earnings — reflects growth

0.04x

✓ Very cheap

My positionTop 5%

Low range Average High range

Medical Care Facilities median 18.77x · Top 1% — relatively cheap within the industry

💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

0.00x

✓ Very pricey

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

0.76x

✓ Cheap

My positionMid-range

Low range Average High range

Medical Care Facilities median 0.92x · Around the industry average

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

Analyst target price (reference)

$42.36 vs. current price +3934.3%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: Medical Care Facilities

Who owns it?

Ownership is broadly stable

Short interest light 2.0% · Short interest up +1.8pp over last 20d

👥 Holdings composition

🏦 Institutions 0.0%

Retail-led

Healthcare 초소형주 Median 14.2%

🧑‍💼 Insiders 0.0%

Low, common among large-caps

Healthcare 초소형주 Median 16.1%

👤 Retail investors (estimated) 100.0%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

2.0%

Low — limited short-side pressure

Healthcare 초소형주 Median 3.9%

Past 20 days 📈 +1.8%p increase

Short interest days to cover

0.0 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 3.4M주

Float (tradable shares) 3.4M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 20 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
NIVF This Stock	$3.6M	-	0.0 ▲	-	-	-4.5%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

FAQ

What kind of company is 뉴젠아이브 그룹(NIVF)?

뉴젠아이브 그룹(NIVF) belongs to the Healthcare sector and operates in the Medical Care Facilities industry.

What is the market cap of NIVF?

The market cap of NIVF is approximately $4M, ranking 5,736 within its sector.

What is the 52-week high and low for NIVF?

NIVF has recorded a 52-week high of $568.53 and a low of $1.10.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.